Rep. Gilbert Cisneros (D-CA) Buys Boston Scientific (BSX) Stock
California Congressman Gilbert Cisneros purchased shares of Boston Scientific, reflecting his interest in the healthcare sector.
Reviewed by automated data checks against the source filing. How we make and check alerts
Rep. Gilbert Cisneros (D-CA) bought between $1,001 and $15,000 of Boston Scientific Corporation ($BSX) stock on May 19, 2026. The trade was disclosed in a STOCK Act periodic transaction report filed June 9, 2026.
Since the trade, $BSX is up 1.5% after 1 week, down 20.3% after 1 month and down 21.9% to date (from the $56.81 close on May 19, 2026).
Financial Disclosure Report
Clerk of the House of Representatives • Legislative Resource Center • B81 Cannon Building • Washington, DC 20515
Filer Information
- Name:
- Rep. Gilbert Cisneros (D-CA)
- Status:
- Member — House
- State/District:
- CA-31
- Party:
- democrat
Filing Information
- Filing Type:
- Periodic Transaction Report
- Filing Year:
- 2026
- Filing Date:
- Jun 9, 2026
Schedule B: Transactions
| Asset | Transaction | Date | Amount |
|---|---|---|---|
| Boston Scientific Corporation ($BSX) | Buy | May 19, 2026 | $1,001 - $15,000 |
Summary of the filed report, not the original document. Find the original: House financial disclosure search
BSX
Boston Scientific Corporation
Key Points
- Gilbert Cisneros, a Democrat from California's 31st district, bought Boston Scientific shares valued between $1,001 and $15,000 on May 19, 2026.
- The stock closed at $42.60 on the day of the purchase, which is near its 52-week low of $41.39.
- Boston Scientific has a market cap of about $63.97 billion and a P/E ratio of 17.87, with analysts maintaining a consensus buy recommendation.
Get $BSX trade alerts by text
We text you when insiders, Congress or big funds trade $BSX. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Boston Scientific Corporation alert may contain errors. Disclosures
Overview of the Purchase
On May 19, 2026, Gilbert Cisneros, a Democrat representing California's 31st district in the House, bought shares of Boston Scientific Corporation (NYSE: BSX) valued between $1,001 and $15,000. The transaction was reported on June 9, 2026. This purchase comes as Boston Scientific operates in the healthcare sector, focusing on medical devices used in various interventional specialties.
Gilbert Cisneros vs. the S&P 500
Hypothetical returns from Gilbert Cisneros's disclosed trades, not real profit or advice. How we model this.
Why This Trade Matters
Cisneros' purchase reflects his ongoing interest in the healthcare sector, particularly as he serves on committees that may influence healthcare policy. The shares were bought at a time when Boston Scientific's stock closed at $42.60, which is close to its 52-week low of $41.39. This suggests that he may see potential in the company's future performance.
Analysts Set New Price Targets
Boston Scientific has been under the watchful eyes of analysts recently. On October 14, 2026, Truist Securities maintained a Buy rating with a price target of $51, down from a previous target of $57. Barclays initiated coverage with an Equal-Weight rating and a target of $48 on October 7, 2026. Citigroup also maintained a Neutral rating with a target of $48, while Wells Fargo kept its Equal-Weight rating with a target of $48 on September 24, 2026. Overall, analysts have maintained a consensus recommendation of Buy, with a mean price target of about $59.24.
Company Background
Boston Scientific Corporation develops and markets medical devices for various medical fields worldwide. The company’s products range from devices for gastrointestinal and urological conditions to technologies for heart disease and neurological disorders. This trade by Cisneros may indicate his support for the company’s mission and its potential impact on healthcare.
What's Ahead for Boston Scientific Corporation
Cisneros' transaction is part of a broader trend of lawmakers disclosing stock trades, which reflect their investment choices. The next earnings report for Boston Scientific is scheduled for October 28, 2026. Investors and analysts will be watching closely to see how the company performs and if it meets the expectations set by recent ratings.
Related Filing Alerts
Source: Gilbert Cisneros's STOCK Act disclosure on $BSX (May 19, 2026). Find the original filing: House financial disclosure search. Written by software, not financial advice. How we make alerts